SPARC and central nervous system cancer: In fact, SPARC functions in an autocrine/paracrine mechanism to inhibit proliferation and tumor formation of glioma cells and enhance FAK/Rho/F-actin-mediated migration and invasion, whereas IRE1 hydrolyses SPARC mRNA to induce the opposite effect (Figure 5) [214].